ArticleACS chemical biology2021

Fragment Screening Reveals Starting Points for Rational Design of Galactokinase 1 Inhibitors to Treat Classic Galactosemia.

Sabrina R Mackinnon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.